Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cell Pathways commences phase III trial for prevention of precancerous colon polyps

May 16, 1997

BMS and RTI form anticancer alliance

May 15, 1997

NeoPharm licenses broxuridine to BioChem Therapeutic

May 15, 1997

New hypoxic cytotoxin from Evanston Hospital

May 15, 1997

PAK-104P reverses both P-glycoprotein- and MRP-mediated MDR

May 15, 1997

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

May 15, 1997

Pharmacokinetics and tissue distribution of TOP-53

May 15, 1997

Samjin characterizes novel antitumor agent

May 14, 1997

In vitro effects of combinations of tubulin-interacting agents and S-16020-2

May 14, 1997

Biota licenses compounds for the treatment of prostate cancer

May 14, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...